Development of vaccines at the time of COVID-19

Jeffrey Almond, Jörg Hacker, Colin Harwood, Mariagrazia Pizza, Rino Rappuoli, Eliora Z. Ron*, Philippe Sansonetti, Samantha Vanderslott, Lothar H. Wieler

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Following the rapid and unpredicted spread of COVID-19 in the first seven months of 2020, the need to develop vaccines for pandemic viruses rapidly has been clearly established. Thus, this paper will concentrate on points that were highlighted by the recent COVID-19 pandemic and lessons learnt therefrom.

Original languageEnglish
Article numberuqaa003
JournalMicroLife
Volume1
Issue number1
DOIs
StatePublished - 2020

Keywords

  • COVID-19
  • pandemics
  • pathogens
  • vaccination
  • vaccines
  • vaccinology

Fingerprint

Dive into the research topics of 'Development of vaccines at the time of COVID-19'. Together they form a unique fingerprint.

Cite this